Regulatory risk Significant regulatory action and a large settlement related to AKS and False Claims Act violations indicate heightened compliance and governance risk for Cardiac Imaging's PSO model. Potential buyers should seek robust compliance frameworks and audit trails when evaluating partnerships or subcontractors.

Revenue potential Reported annual revenue in the range of fifty to a hundred million suggests substantial scale and a proven service model. Opportunities exist to upsell expanded mobile PET coverage, fixed-site installations, or turnkey service add-ons to larger hospital networks seeking cardiac PET capabilities.

Partnership leverage Existing collaborations with DraxImage and ScImage imply a track record of strategic partnerships. Target similar imaging groups and hospital systems that value turnkey, on-site PET services to accelerate deployment and minimize in-house capital expenditure.

Niche advantage Focused exclusively on cardiac PET imaging positions Cardiac Imaging as a specialized provider with potential for premium pricing and deep domain expertise. Sales plays can emphasize gold-standard PET accuracy for early coronary disease detection to differentiate from broader nuclear medicine vendors.

Growth channels Mobile clinics paired with fixed-site installations present a scalable model for hospital networks seeking flexible coverage and rapid expansion. Explore multi-site contracts, fleet expansion, and digital marketing services together with existing tech stack (Google Cloud, Salesforce, WordPress) to streamline adoption and ongoing account management.